{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:57:49Z","timestamp":1790629069864,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.numecd.2023.01.013","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:21:33Z","timestamp":1674627693000},"page":"947-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4394-9454","authenticated-orcid":false,"given":"Tae Kyung","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-9226","authenticated-orcid":false,"given":"Mi Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-2631","authenticated-orcid":false,"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-7753","authenticated-orcid":false,"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Chul","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.01.013_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2016.05.026","article-title":"Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver","volume":"65","author":"Sung","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.numecd.2020.02.016","article-title":"Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy","volume":"30","author":"Petta","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.01.013_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.numecd.2021.01.009","article-title":"Does a high intake of green leafy vegetables protect from NAFLD? Evidence from a large population study","volume":"31","author":"Li","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.01.013_bib5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","article-title":"Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension","volume":"60","author":"Sung","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1136\/gutjnl-2020-323202","article-title":"From the origin of NASH to the future of metabolic fatty liver disease","volume":"70","author":"Geier","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.01.013_bib7","first-page":"12","article-title":"MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality?","volume":"2","author":"Lombardi","year":"2022","journal-title":"Metabolism Target Organ Damage"},{"issue":"5","key":"10.1016\/j.numecd.2023.01.013_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.01.013_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.01.013_bib11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/hep.23789","article-title":"Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data","volume":"52","author":"Ghouri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.01.013_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32519","article-title":"Risk of cardiovascular disease and loss in life expectancy in NAFLD","author":"Shang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.01.013_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.01.013_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.01.013_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/clc.22529","article-title":"Fatty liver, insulin resistance, and obesity: relationships with increase in coronary artery calcium over time","volume":"39","author":"Sung","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.numecd.2023.01.013_bib16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.01.013_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2021.04.028","article-title":"Non-alcoholic fatty liver disease in adults 2021: a clinical practice guideline of the Italian association for the study of the liver (aisf), the Italian society of diabetology (SID) and the Italian society of obesity (SIO)","volume":"32","year":"2022","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.01.013_bib18","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.numecd.2021.08.037","article-title":"Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic\/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study","volume":"31","author":"Targher","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.01.013_bib19","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1038\/s41598-022-10032-2","article-title":"Association between physical activity and insulin resistance using the homeostatic model assessment for insulin resistance independent of waist circumference","volume":"12","author":"Yoo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2023.01.013_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.numecd.2019.01.016","article-title":"Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese","volume":"29","author":"Sung","year":"2019","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.01.013_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.32131","article-title":"Metabolic dysfunction\u2013associated fatty liver disease improves detection of high liver stiffness: the Rotterdam Study","volume":"75","author":"van Kleef","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.01.013_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.32131","article-title":"Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: the Rotterdam Study","volume":"75","author":"van Kleef","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.01.013_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2023.01.013_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7570\/jomes.2019.28.1.40","article-title":"Korean society for the study of obesity guideline for the management of obesity in Korea","volume":"28","author":"Seo","year":"2018","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.numecd.2023.01.013_bib26","article-title":"NAFLD or MAFLD: which has closer association with all-cause and cause-specific mortality?-results from NHANES III","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.numecd.2023.01.013_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.05.029","article-title":"Differential clinical characteristics and mortality outcomes in persons with NAFLD and\/or MAFLD","volume":"19","author":"Nguyen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5009\/gnl210167","article-title":"Consortium obotiteon. Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease","volume":"16","author":"Moon","year":"2022","journal-title":"Gut and Liver"},{"key":"10.1016\/j.numecd.2023.01.013_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.numecd.2023.01.013_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13098-022-00811-2","article-title":"Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease","volume":"14","author":"Han","year":"2022","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.numecd.2023.01.013_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245762","article-title":"Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study","volume":"16","author":"Niriella","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2023.01.013_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12072-021-10157-y","article-title":"Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?","volume":"15","author":"Guerreiro","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.numecd.2023.01.013_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12933-022-01518-4","article-title":"Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex","volume":"21","author":"Matsubayashi","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2023.01.013_bib34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2020.12.016","article-title":"Clinical utility of the MAFLD definition","volume":"74","author":"Zheng","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.01.013_bib36","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12072-021-10252-0","article-title":"Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control study","volume":"15","author":"Liu","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.numecd.2023.01.013_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41043-017-0114-0","article-title":"Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome","volume":"36","author":"Jahangiry","year":"2017","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.numecd.2023.01.013_bib38","doi-asserted-by":"crossref","first-page":"e2023242","DOI":"10.1001\/jamanetworkopen.2020.23242","article-title":"Performance of the pooled cohort equations to estimate atherosclerotic cardiovascular disease risk by body mass index","volume":"3","author":"Khera","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.numecd.2023.01.013_bib39","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/liv.15259","article-title":"Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction-associated fatty liver disease in Korea","volume":"42","author":"Kim","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2023.01.013_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5009\/gnl210167","article-title":"Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease","volume":"16","author":"Moon","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.numecd.2023.01.013_bib41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jama.2017.0947","article-title":"Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States","volume":"317","author":"Micha","year":"2017","journal-title":"JAMA"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:25:01Z","timestamp":1760545501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475323000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0939475323000248"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.01.013","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}